Literature DB >> 10553024

A rapid and sensitive approach to mutation detection using real-time polymerase chain reaction and melting curve analyses, using BRCA1 as an example.

G Pals1, K Pindolia, M J Worsham.   

Abstract

BACKGROUND: The detection of 2 recurrent mutations in the BRCA1 gene (Ashkenazi Jewish and Dutch populations) was studied with real-time polymerase chain reaction (PCR) and melting curve analyses.
METHODS: PCR products were designed around the 185delAG in exon 2 and the single- base substitution 2841G>T in exon 11. Hybridization probe sets were designed for both PCR products, with each probe overlapping the specific mutation. The exon 11 probe set also covered another mutation, the 2814insA. The 39 end of the 59 probe was labeled with fluorescein isothiocyanate and the 59 end of the 39 probe with LightCycler Red 640 (Roche Diagnostics, Indianapolis, IN).
RESULTS: The 185del and 2841G mutations were easily detected with the hybridization probes, resulting in dual peaks for heterozygotes in melting curve analyses. The differences in melting characteristics of the heteroduplexes in heterozygotes were not detectable with SYBR Green I.
CONCLUSION: For known mutations, melting curve analyses using hybridization-specific probes provide a sensitive, rapid, and efficient approach to mutation detection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10553024     DOI: 10.1016/s1084-8592(99)80027-7

Source DB:  PubMed          Journal:  Mol Diagn        ISSN: 1084-8592


  4 in total

1.  Real-time polymerase chain reaction for the rapid detection of group B streptococcal colonization in neonates.

Authors:  Girija Natarajan; Yvette R Johnson; Fan Zhang; Kang Mei Chen; Maria J Worsham
Journal:  Pediatrics       Date:  2006-07       Impact factor: 7.124

2.  Housekeeping genes as internal standards in cancer research.

Authors:  Nico Janssens; Michel Janicot; Tim Perera; Annette Bakker
Journal:  Mol Diagn       Date:  2004

3.  Prediction of epidermal growth factor receptor mutations in the plasma/pleural effusion to efficacy of gefitinib treatment in advanced non-small cell lung cancer.

Authors:  Guo Jian; Zhou Songwen; Zhang Ling; Deng Qinfang; Zhang Jie; Tang Liang; Zhou Caicun
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-14       Impact factor: 4.553

4.  Multidrug-resistance proteins are weak tumor associated antigens for colorectal carcinoma.

Authors:  Christina S Mullins; Sven Eisold; Ernst Klar; Michael Linnebacher
Journal:  BMC Immunol       Date:  2011-07-10       Impact factor: 3.615

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.